is a very common form of metastatic spread in gastric cancer patients, and disseminated peritoneal lesions are usually untreatable due to their high resistance to chemotherapy (5, 6). While the effect ...

Stage 3 ovarian cancer has spread outside the pelvis into the abdominal cavity or to lymph nodes. Treatment includes surgery and chemotherapy. Stage 3A1 means the cancer has spread to the lymph nodes ...

umontreal.ca Objectives To investigate employment in an occupation or industry and specific occupational exposures in relation to ovarian cancer risk. Methods In a population-based case–control study ...

The omentum is a common site of peritoneal metastasis in various cancers, including gastric cancer. It contains immune cell aggregates known as milky spots, which provide a microenvironment for ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer. Detection of plasma ...

Data from All 50 States Shows Early Onset Breast Cancer Is on the Rise in Younger Women: Does Place of Exposure Matter? Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary ...

Surgery is also recommended if there's any concern an ovarian cyst could be cancerous, or if a person has other risk factors for ovarian cancer. Ovarian cysts often go away on their own but in some ...

Background Hereditary causes of ovarian cancer include Lynch syndrome, which is due to inherited pathogenic variants affecting one of the four mismatch repair genes involved in DNA repair. The aim of ...

Drinking green tea may increase the survival rates of some cancer patients. One study of women with ovarian cancer found that women who drank green tea were more likely to survive 3 years after ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).